Published Date: 13 Mar 2023
Among other things, international students seek connections and advice on how to better compete by supporting community groups.
Read Full NewsHow a cardiac procedure exposed the tension between a mother’s autonomy and her son’s medical expertise.
A young woman grieving a miscarriage was labeled "hysteria." Dr Loshi Rajen reflects on diagnostic bias, the enduring power of psychiatric labels, and the importance of recognizing normal grief.
Doctors are no longer the only source of medical knowledge in the room, and the future may depend on who preserves the most humanity.
Emerging research suggests vulnerability to substance use disorders may begin before the first drink or drug. Drs Leslie A. Hulvershorn and Paola P. Mattey Mora explain why.
Symptomatic relief from nerve stimulation treatment may persist after stopping the treatment in most children with overactive bladder.
Unsweetened dairy may help protect enamel, but added sugar can erase the benefit. Breastfeeding and milk alternatives also have surprising age- and product-specific effects.
In primary care settings, recognizing the difference between seborrheic keratosis and melanoma can guide timely biopsy and reduce missed diagnoses.
1.
It Is Cancer in Kate Middleton.
2.
For elderly, unfit patients, the all-oral AML regimen shows promise.
3.
Pretreatment Liver Tests Often Overlooked in CDK4/6 Therapy
4.
Adaptive SABR-Used Hypofractionated Chemoradiation Showed Good Results in NSCLC.
5.
Limits to Anti-Nausea Pill Coverage Wear on Cancer Patients and Doctors
1.
Unraveling the Mysteries of Coagulopathy: A Comprehensive Definition
2.
Innovative Directions in Hematology Across Clinical Settings
3.
Hypercoagulable State: Factors that Contribute to Blood Clots
4.
Advanced Pathways in Oncology for Better Care
5.
Beyond the Biopsy: Decoding Tumor Biology Through the Lens of Radiogenomics
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part II
2.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V
4.
Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World
5.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation